QR Code

Tezepelumab achieves improvement of severe uncontrolled asthma and rhinosinusitis: Case series

Tezepelumab, a mAb targeting thymic stromal lymphopoietin (TSLP), reduces exacerbations in severe asthma. Four cases in which patients with severe asthma and chronic rhinosinusitis with nasal polyps showed improvements in both conditions after receiving tezepelumab treatment are presented.

Enregistré dans:
Auteurs principaux: Shigesato Inoue, MD, Hiroaki Ogata, MD, PhD, Yoichi Dotake, MD, Koichi Takagi, MD, PhD, Ayaka Shiota, MD, Yumiko Ishii, MD, PhD, Kentaro Tanaka, MD, PhD, Keiko Kan-o, MD, PhD, Hiromasa Inoue, MD, PhD
Format: Artigo
Langue:Inglês
Publié: Elsevier 2025-05-01
Collection:Journal of Allergy and Clinical Immunology: Global
Sujets:
Asthma control
tezepelumab
rhinosinusitis
severe asthma
nasal polyps
Accès en ligne:http://www.sciencedirect.com/science/article/pii/S2772829325000499
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires